CatalystWireBeta

Half-year Results

In brief · summary, not quotable

Ovoca Bio reports interim results for H1 2025 with €1,526m cash; Tadeen acquisition progressing.

  • Cash and cash equivalents €1,526m
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your TLM notes

Dublin, Ireland, 30 September 2025 - Ovoca Bio announces its interim financial statements and report covering the six-months ending 30 June 2025.

Please click on the following link to view the full Half Year Report and extracts are set out at the end of this announcement:

Ovoca News - Ovoca Bio

CEO Statement

Today we have published Ovoca's financial statements covering the six-month period to the end of June 2025, which I encourage all stakeholders to read. On 7 May 2025 the Company entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen International Limited ("Tadeen"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the "Proposed Acquisition"). The team at Ovoca has been working to complete the Proposed Acquisition and in due course further announcements will be made as we finalize the acquisition of Tadeen.

As at 30 June 2025, the Company had cash and cash equivalents amounting to €1,526 million ($ 1,788 million) and we will continue to carefully manage our financial resources. The costs incurred during the period relate to the costs of work in relation to the Proposed Acquisition along with corporate costs.

I would like to thank the management team of the Company and the Board of Directors for their support.

Half Year Report

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note